Cencora (COR) recently executed a distribution services agreement with Citius Oncology, signaling an expansion in its pharmaceutical distribution capabilities. Over the past quarter, Cencora’s share ...

COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.

Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their ...

Hospital operator HCA Healthcare, Inc. HCA is set to report second-quarter 2025 results on July 25, before the opening bell.

Willis Chandler is the new president and CEO of Knipper Health. The news came alongside the announcement that Frazier ...

DENTSPLY SIRONA XRAY is well-positioned for growth due to its new digital-implant workflowand continued focus on research and development. However, forex headwinds and demand softness in Europe ...

Ecolab ECL recently launched an innovative cleaning solution, Ecolab ReadyDose, specifically designed for food service ...

Boston Scientific’s BSX robust MedSurg segment, driven by endoscopy, neuromodulation and urology businesses, is poised for ...

As supply chain disruption persists in pharma, global logistics providers with the expertise to overcome any challenge are essential.

Fresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a solid global foothold. However, a tough regulatory environment remains a ...

Abbott LaboratoriesABT is slated to report second-quarter 2025 results on July 17, before the opening bell. The company ...